BRIEF-Obagi Medical Products up in premarket; to be acquired by Valeant Pharma

NEW YORK, March 20 Wed Mar 20, 2013 8:34am EDT

NEW YORK, March 20 (Reuters) - Obagi Medical Products Inc : * Up 28.3 percent to $19.75 in premarket; to be acquired by Valeant Pharmaceuticals for $19.75 per share

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.